Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.79% |
| 2 | Healthcare | 13.71% |
| 3 | Financials | 10.83% |
| 4 | Industrials | 9.88% |
| 5 | Consumer Staples | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DVD
2551
DELISTED
Dover Motorsports
DVD
| $820K | ﹤0.01% |
352,000
+5,600
| +2% | +$12.6K |
|
|
LGF
2552
DELISTED
Lions Gate Entertainment
LGF
| $819K | ﹤0.01% |
+25,298
| New | +$931K |
|
2553
Weibo
WB
$1.88B
| $815K | ﹤0.01% |
+41,800
| New | +$717K |
|
|
ONE
2554
DELISTED
HIGHER ONE HOLDINGS, INC COM STK
ONE
| $813K | ﹤0.01% |
250,811
+89,811
| +56% | +$257K |
|
|
AGU
2555
DELISTED
Agrium
AGU
| $810K | ﹤0.01% |
+9,069
| New | +$858K |
|
2556
Weyco Group
WEYS
$446M
| $808K | ﹤0.01% |
30,200
-9,500
| -24% | -$262K |
|
|
ACFC
2557
DELISTED
Atlantic Coast Financial Corporation
ACFC
| $808K | ﹤0.01% |
137,800
+22,000
| +19% | +$133K |
|
|
NAVB
2558
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $807K | ﹤0.01% |
30,330
+8,380
| +38% | +$291K |
|
2559
Nomura Holdings
NMR
$29B
| $805K | ﹤0.01% |
145,000
+50,100
| +53% | +$305K |
|
|
HZN
2560
DELISTED
Horizon Global Corporation
HZN
| $805K | ﹤0.01% |
+77,600
| New | +$707K |
|
|
JCTC
2561
Jewett-Cameron Trading
JCTC
$10.3M
| $803K | ﹤0.01% |
159,800
+2,000
| +1% | +$9.73K |
|
|
TVRD
2562
Tvardi Therapeutics
TVRD
$22.1M
| $802K | ﹤0.01% |
1,321
-5,668
| -81% | -$3.11M |
|
|
MIXT
2563
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $801K | ﹤0.01% |
189,900
+46,700
| +33% | +$238K |
|
|
SHOE
2564
Shoe Station Group
SHOE
$420M
| $798K | ﹤0.01% |
68,800
-97,600
| -59% | -$1.08M |
|
2565
Malibu Boats
MBUU
$576M
| $794K | ﹤0.01% |
48,500
-28,518
| -37% | -$430K |
|
|
MSB
2566
Mesabi Trust
MSB
$306M
| $794K | ﹤0.01% |
+175,700
| New | +$1.35M |
|
|
ELON
2567
DELISTED
Echelon Corp
ELON
| $792K | ﹤0.01% |
140,427
+24,467
| +21% | +$148K |
|
|
SA
2568
Seabridge Gold
SA
$3.5B
| $789K | ﹤0.01% |
+95,240
| New | +$748K |
|
|
ADVM
2569
DELISTED
Adverum Biotechnologies
ADVM
| $782K | ﹤0.01% |
+8,210
| New | +$721K |
|
2570
Dave & Buster's
PLAY
$370M
| $781K | ﹤0.01% |
18,700
-200,100
| -91% | -$7.83M |
|
2571
Aspen Aerogels
ASPN
$504M
| $778K | ﹤0.01% |
128,100
+32,142
| +33% | +$222K |
|
2572
Ultralife
ULBI
$120M
| $778K | ﹤0.01% |
120,500
+60,800
| +102% | +$401K |
|
|
FPI
2573
Farmland Partners
FPI
$425M
| $770K | ﹤0.01% |
70,206
+54,506
| +347% | +$588K |
|
2574
Hecla Mining
HL
$11.9B
| $770K | ﹤0.01% |
407,569
+78,500
| +24% | +$163K |
|
|
CSLT
2575
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $767K | ﹤0.01% |
179,742
+50,842
| +39% | +$218K |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.